Delivery Order SPE2DB22D2007-SPE2DB24FJ6CP

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB22D1106|SPE2DB24FFLQ3, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of VYVANSE 50 MG CAPSULE 100S. The contract has a ceiling value of $5,455.56 and an ultimate completion date of September 10, 2024. This award is not set-aside and is a Delivery Order under a Firm Fixed Price contract type. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has been awarded...
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDSD8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $12,376.39 and a completion date of December 30, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a...
The federal contract award SPE2DB24D2012|SPE2DB24FBUQM was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4564212807 VYVANSE 40 MG CAPSULE 100S. This is a firm fixed price delivery order contract with a ceiling value of $2,272.76 and a performance period through April 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through...
This federal contract award, with a total ceiling value of $1,512.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, identified as SPE2DB20D1004|SPE2DB25FNDWF, is a Delivery Order for the procurement of 4566822669 VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of January 3, 2025. This award is...
This federal contract award, with ID SPE2DB22D1002|SPE2DB25FKYA8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the supply of 4567237364 - VYVANSE 30 MG CAPSULE 100S. The contract has a ceiling value of $1,120.49 and an ultimate completion date of February 12, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, with ID SPE2DB24D3013|SPE2DB25FFKQL, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4567781919 ! VYVANSE 50 MG CAPSULE 100S. The contract has a ceiling value of $1,859.01 and is a Firm Fixed Price Delivery Order. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, with no major subcontractors mentioned. This contract is part of a larger...
This federal contract award, identified as SPE2DB24D1034|SPE2DB25FWAN1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567291398 VYVANSE 50 MG CAPSULE 100S, a prescription medication, with a ceiling value of $1,155.86. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 18, 2025. The...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB25FZ20U, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,784.96, is a delivery order for the supply of 4566529414 - VYVANSE 10 MG CAPSULE 100S. The contract has a firm fixed price and an ultimate completion date of November 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award, with ID SPE2DB24D1104|SPE2DB25FXZV5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,192.05 Firm Fixed Price delivery order is for the supply of 4567903376 VYVANSE 50 MG CAPSULE 100S. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to...
The federal contract award SPE2DB22D3010|SPE2DB24FP2HU was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4564543055 - VYVANSE 50 MG CAPSULE 100S. The contract has a firm fixed price of $1,896.82 and a completion date of May 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide a range of...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ6CP
    Delivery Order

This federal contract award with ID SPE2DB22D2007|SPE2DB24FJ6CP was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of 4565802104 VYVANSE 50 MG CAPSULE 100S. The firm fixed price delivery order has a ceiling value of $19,360.50 and an ultimate completion date of September 16, 2024. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, will be responsible for providing the required medication to support federal healthcare programs and military treatment facilities nationwide. The DLA is the primary customer for this award, which is likely part of a larger Indefinite Delivery Contract (IDC) Amerisourcebergen holds with the agency to supply a comprehensive range of pharmaceutical products and medical supplies.

Generated 12/13/24, 9:38 AM